Cachexia

From WikiMD's Medical Encyclopedia

Revision as of 21:08, 4 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Cachexia
Synonyms Wasting syndrome
Pronounce N/A
Specialty N/A
Symptoms Weight loss, muscle atrophy, fatigue, weakness, loss of appetite
Complications Infection, organ failure
Onset Gradual
Duration Long term
Types N/A
Causes Cancer, chronic obstructive pulmonary disease, chronic heart failure, chronic kidney disease, AIDS
Risks Chronic illness, advanced age
Diagnosis Clinical assessment, body mass index (BMI) < 20 kg/m², unintentional weight loss > 5% in 6 months
Differential diagnosis Anorexia nervosa, depression, malabsorption
Prevention N/A
Treatment Nutritional support, appetite stimulants, anti-inflammatory drugs, exercise
Medication Megestrol acetate, corticosteroids, anabolic steroids
Prognosis Poor, often associated with increased mortality
Frequency Common in advanced cancer and chronic illness
Deaths N/A


Cachexia is a complex metabolic syndrome associated with underlying illness and characterized by loss of muscle with or without loss of fat mass. The prominent clinical feature of cachexia is weight loss in adults or growth failure in children. Cachexia is distinct from starvation, age-related loss of muscle mass (sarcopenia), primary depression, malabsorption, and hyperthyroidism.

Etiology[edit]

Cachexia is commonly associated with chronic diseases such as cancer, chronic obstructive pulmonary disease (COPD), chronic kidney disease, chronic heart failure, and acquired immunodeficiency syndrome (AIDS). The pathophysiology of cachexia involves a complex interaction between pro-inflammatory cytokines, neuroendocrine hormones, and metabolic abnormalities.

Pathophysiology[edit]

The pathophysiology of cachexia is multifactorial and involves:

  • Increased levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-Œ±), interleukin-6 (IL-6), and interleukin-1 (IL-1).
  • Altered metabolism of carbohydrates, proteins, and fats.
  • Increased muscle protein degradation and decreased muscle protein synthesis.
  • Anorexia and reduced food intake due to the effects of cytokines and other factors on the central nervous system.

Clinical Features[edit]

The clinical features of cachexia include:

  • Significant weight loss over a short period.
  • Muscle wasting and loss of muscle strength.
  • Fatigue and weakness.
  • Anorexia and reduced food intake.
  • Edema in some cases.

Diagnosis[edit]

The diagnosis of cachexia is primarily clinical and based on the presence of significant weight loss and muscle wasting in the context of an underlying chronic disease. Diagnostic criteria may include:

  • Unintentional weight loss of more than 5% of body weight over 6-12 months.
  • Body mass index (BMI) less than 20 kg/m¬≤ in adults.
  • Reduced muscle strength and physical performance.

Management[edit]

The management of cachexia involves a multidisciplinary approach, including:

  • Nutritional support to increase caloric and protein intake.
  • Pharmacological interventions such as appetite stimulants, anti-inflammatory agents, and anabolic agents.
  • Physical exercise to improve muscle mass and strength.
  • Treatment of the underlying disease to reduce the inflammatory response.

Prognosis[edit]

Cachexia is associated with poor prognosis and increased mortality, particularly in patients with advanced cancer and chronic heart failure. Early recognition and intervention are crucial to improve outcomes and quality of life.

See Also[edit]

References[edit]

External Links[edit]

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.